MDx Partners, LLC offers physician group practices involved in wound care and podiatry the only comprehensive turnkey laboratory development and oversight model. This allows the group partnership to provide the highest level of molecular diagnostics to their patients, while retaining laboratory revenues that are commonly sent out to independent clinical reference laboratories.
The MDx Partners, LLC model provides all CLIA regulatory, clinical methodology development, instrumentation and equipment, personnel training and lab operational oversight necessary for a physician office laboratory (POL). Please review this website for more information on this physician group practice lab ownership model to include more specific information on our services, the technology and the regulatory basis for allowing physician group practices to own and refer patient specimen to their POL.
MDx Partners
About Us
MDx Partners is run by an experienced lab management team that has built and managed 15 licensed and certified laboratories for physician group practices and investor groups over the last decade. We employ highly credentialed CLIA compliance team and maintain a staff of seasoned laboratory personnel to train new hires and supervise all of our clients’ laboratory operations.
MDx Partners offers its physician group practice clients a comprehensive and turnkey CLIA high-complexity clinical diagnostic laboratory testing solution focused on pathogen (bacteria and fungi) identification utilizing real-time polymerase chain reaction (RT-PCR) and next generation sequencing (NGS). These cutting edge diagnostic tools are well suited for the wound care and nail fungus treatment markets.
In MDx Partners, Physicians and other healthcare professionals in these markets have a true partner that intimately understands and rapidly responds to their needs. Our lab development and oversight personnel will work in cooperation with the healthcare professionals they serve, to assist them in providing the basis for the most accurate patient diagnostics available today.
MDx Partners offers the exclusive "CE4MD "Program to raise the level of diagnostics provided to physician group practices and their patients.
Explore
Diagnostic Technologies for Pathogen Identification
Microbiology Culture
-
Nearly 200 years old
-
Results in 2-4 weeks
-
60% accuracy
-
Identifies less than 1% of the known human pathogens
-
Real-Time PCR
-
Modern technology
-
Results within 48 hours
-
99% accuracy, limited to small panels of pathogens
-
Bacterial resistant genes
-
Next Generation Sequencing (NGS)
-
Cutting edge technology
-
Results in 3 to 5 days
-
99.9% accuracy
-
25,000 human pathogens
Grow Your Practice
Physicians and group medical practices rely on the Stark law’s in-office ancillary services exception rule and physician services exceptions to allow "within-practice" DHS referrals, to include laboratory testing. This exception allows providers in group practices to:
-
Make in-office lab referrals
-
Bill Medicare & Medicaid
-
Retain and use these revenues for group practice expenses and physician compensation
Services
